High materiality7/10
MBX Biosciences price target raised to $90 from $60 at UBS
Why it may matterVerify against the original reporting
Upside potential on higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises MBX target to $90 from $60; current price $61.84; priceChangeSinceSignal -0.95.
- Target $90; price $61.84; change -0.95
- UBS target up; upside potential
Key facts
- 01
Target: $90
- 02
Posted price: $61.84
- 03
Analyst firm: UBS
- 04
Analyst: Michael Yee
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.